Pratz, Keith W.Jonas, Brian A.Pullarkat, VinodThirman, Michael J.Garcia, Jacqueline S.Döhner, HartmutRecher, ChristianFiedler, WalterYamamoto, KazuhitoWang, JianxiangYoon, Sung-SooWolach, OfirYeh, Su-PengLeber, BrianEsteve, JordiMayer, JiriPorkka, KimmoIllés, ÁrpádLemoli, Roberto M.Turgut, MehmetKu, GraceMiller, CatherineZhou, YingZhang, MengChyla, BrendaPotluri, JalajaDiNardo, Courtney D.2024-03-072024-03-072024American Journal Of Hematology. -99 : 4 (2024), p. 615-624. -Am. J. Hematol. - 0361-8609. - 1096-86521096-86520361-8609https://hdl.handle.net/2437/367242Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemiafolyóiratcikkopen access articlehttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM119187OrvostudományokKlinikai orvostudományokhttps://onlinelibrary.wiley.com/doi/10.1002/ajh.27246szerzőhttp://dx.doi.org/10.1002/ajh.272462024-03-0700124052960000185185111057